Bowhead Specialty (NYSE:BOW) Releases Earnings Results, Beats Estimates By $0.03 EPS

Bowhead Specialty (NYSE:BOW) announced its earnings results on Tuesday. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.03, Zacks reports. The business had revenue of $171.77 million for the quarter, compared to analyst estimates of $278.64 million. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%.

Bowhead Specialty Price Performance

BOW stock traded up $0.07 during mid-day trading on Wednesday, hitting $34.23. The stock had a trading volume of 29,866 shares, compared to its average volume of 245,540. The firm has a fifty day simple moving average of $33.87 and a 200 day simple moving average of $28.63. The firm has a market capitalization of $1.13 billion, a P/E ratio of 18.50, a P/E/G ratio of 1.00 and a beta of -0.06. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. Bowhead Specialty has a 52 week low of $21.21 and a 52 week high of $35.07.

More Bowhead Specialty News

Here are the key news stories impacting Bowhead Specialty this week:

• Positive Sentiment: Bowhead earned $0.54 per share, above the $0.51 consensus and up from $0.47 a year earlier. Gross premiums rose 10.8%, indicating continued business growth. Bowhead Q3 earnings top estimates Bowhead Q3 premiums rise
• Neutral Sentiment: Coverage also described the results as preceding a buyout, but the supplied reports do not provide deal terms to assess its potential effect on shareholders. Bowhead Q3 premiums rise ahead of buyout
• Negative Sentiment: The combined ratio rose slightly to 95.9%, signaling some deterioration in underwriting performance, and another report said quarterly income fell. Those trends could temper the positive earnings and premium-growth news. Bowhead reports Q3 earnings beat, combined ratio worsens Bowhead Q3 income falls

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their target price on shares of Bowhead Specialty from $30.00 to $33.00 and gave the company a “neutral” rating in a research note on Monday, July 20th. Piper Sandler downgraded shares of Bowhead Specialty from an “overweight” rating to a “hold” rating and set a $34.00 target price on the stock. in a report on Monday, August 3rd. Keefe, Bruyette & Woods upped their price target on shares of Bowhead Specialty from $34.00 to $36.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 8th. Citigroup cut shares of Bowhead Specialty to a “market perform” rating in a research note on Thursday, September 10th. Finally, Citizens Jmp downgraded shares of Bowhead Specialty from an “outperform” rating to a “market perform” rating in a research report on Thursday, September 10th. Two equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Bowhead Specialty presently has a consensus rating of “Hold” and a consensus price target of $33.50.

About Bowhead Specialty

Bowhead Specialty (NYSE:BOW) is a specialty insurance holding company that provides coverage for complex and hard-to-place risks. Through its insurance subsidiaries, the company primarily underwrites specialty products for businesses and organizations across the United States.

Its offerings include casualty insurance, professional liability coverage, healthcare-related liability products and other specialty lines. Bowhead distributes its products primarily through wholesale insurance brokers, serving customers whose needs may not be met by standard commercial insurance carriers.

The company was established in 2020 and became a publicly traded company in 2024.